Bridgeway Capital Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Bridgeway Capital Management’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-60,000	Closed	-$2.18M	–	1527
2016 Q4	$2.18M	Sell	60,000 -10,000	-14%	-$354K	0.03%	547
2016 Q3	$2.67M	Buy	70,000 +20,000	+40%	+$296K	0.04%	415
2016 Q2	$409K	Hold	50,000	–	–	0.01%	1132
2016 Q1	$310K	Hold	50,000	–	–	0.01%	1204
2015 Q4	$419K	Buy	+50,000	New	+$263K	0.01%	1117

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Bridgeway Capital Management's CLCD Position: Q1 2017 in Review

Bridgeway Capital Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 60,000 shares — an estimated $2.18M sold.

Bridgeway Capital Management first reported a position in CLCD in Q4 2015 and held it in 5 quarters. The position peaked at $2.67M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Bridgeway Capital Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Bridgeway Capital Management sold 60,000 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $2.18M.
Bridgeway Capital Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2015 and held it in 5 quarters.
Bridgeway Capital Management's CoLucid Pharmaceuticals, Inc. position peaked at $2.67M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Bridgeway Capital Management's 13F filing for Q1 2017, filed 15 May 2017.